Clinical feature-related single-base substitution sequence signatures identified with an unsupervised machine learning approach
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: LSTM-SOM clustering of TCGA mutations using flanking sequence features yielded ten mutation classes associated with pathology and patient clinical/survival groupings; these are computational associations, not causal mechanisms.
Technology: machine learning
Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- LSTM extracts sequence features and SOM clusters 2,141,527 SBS from 9,596 TCGA patients; ten mutation-blot classes and K-means patient groups are linked with tumor pathology, clinical features, and survival.
- Limitation / still unknown
- Affiliation not stated in the reviewed material. Affiliation was not available in the reviewed primary bibliographic metadata. Publication status could not be established from the reviewed primary bibliographic metadata.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s12920-021-01144-1
The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.